MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, ACXP has $7,689,535 in assets. $2,420,943 in debts.

Balance Sheets Overview

Debt to Asset Ratio
31.48%
Unit: Dollar
Assets Breakdown
    • Cash
    • Prepaid expenses
    • Other receivable
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Common stock 0.001 par value, 25...

Balance Sheets
2025-12-31
Cash
7,556,100
Other receivable
48,417
Prepaid expenses
85,018
Total assets
7,689,535
Accounts payable and accrued expenses
2,420,943
Total current liabilities
2,420,943
Total liabilities
2,420,943
Common stock 0.001 par value, 250,000,000 shares authorized, 2,348,113 shares issued and outstanding at december 31, 2025 and 200,000,000 shares authorized, 851,534 shares issued and outstanding at december 31, 2024
2,348
Additional paid-in capital
80,554,738
Accumulated deficit
-75,288,494
Total shareholders' equity
5,268,592
Total liabilities and shareholders' equity
7,689,535
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash$7,556,100 Prepaid expenses$85,018 Other receivable$48,417 Total assets$7,689,535 Total liabilities andshareholders' equity$7,689,535 Total shareholders'equity$5,268,592 Total liabilities$2,420,943 Accumulated deficit-$75,288,494 Additional paid-in capital$80,554,738 Total currentliabilities$2,420,943 Common stock 0.001 parvalue, 250,000,000...$2,348 Accounts payable andaccrued expenses$2,420,943

Acurx Pharmaceuticals, Inc. (ACXP)

Acurx Pharmaceuticals, Inc. (ACXP)